SPRY

ARS Pharmaceuticals, Inc.

Healthcare · Biotechnology

$153.13 sample

+1.69 (+1.12%) 1D

Market cap

$866.8B

Price as of

2026-10-03

Latest filing

8-K · 2026-09-10

Alerts

8

Price$153.13 +6.11% 3M daily closessample

155.10135.62

2026-07-072026-07-292026-08-202026-09-102026-10-02

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Sep 28INSInsider sell: Chief Executive Officer
Sep 18INSInsider sell: EVP, Operations
Sep 10SEC8-K filed: material event
Sep 02INSInsider sell: General Counsel
Aug 27INSInsider sell: EVP, Operations
Aug 19INSInsider buy: Chief Financial Officer
Aug 10INSInsider sell: 10% owner
Aug 03INSInsider buy: General Counsel

Sign up to see the real SPRY record →

Company facts

SEC EDGAR registration

Name: ARS Pharmaceuticals, Inc.
Sector: Healthcare
Industry: Biotechnology
Smart-money score: +20sample, -100 to +100
Reporting currency: USD

Who is positioning in SPRY

sample

Insiders: 14 insider transactions over 90 days, net selling, $622.5M
Congress: 2 members traded over 90 days
Institutions · 13F: 16 funds hold $5.7B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$35.5B +17.9% y/y

Q4 2024Q3 2026

Inventory$20.7B +17.0% y/y

Q4 2024Q3 2026

Accounts receivable$15.0B +14.7% y/y

Q4 2024Q3 2026

Total debt$42.7B +11.9% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $322.8B -4.2% 3M
Sample peer B: $227.1B -4.8% 3M
Sample peer C: $424.8B +4.3% 3M
Sample peer D: $170.3B +2.1% 3M
Sample peer E: $193.2B -8.7% 3M